National Comprehensive Cancer Network

NCCN Research & Business Resources

NCCN Oncology Research Program (ORP) Recent News

The NCCN Oncology Research Program (ORP) facilitates all phases of clinical research by identifying investigators and initiating clinical trials at NCCN Member Institutions. The NCCN ORP draws on the expertise of investigators at 28 leading cancer centers and establishes collaborations with pharmaceutical and biotechnology companies in order to advance therapeutic options for patients with cancer. To date, the NCCN ORP has provided almost $30 million in research funding to investigators at NCCN Member Institutions. Click on a press release below to learn more about the NCCN ORP.

• NCCN Announces Research Projects Exploring Axitinib in Various Cancers, in Collaboration with Pfizer  (12/15/2020)
• Grantees Awarded as Part of the Breast Cancer Research Project Between NCCN and Lilly Oncology  (12/03/2020)
• NCCN Oncology Research Program and Puma Biotechnology, Inc. Collaborate to Study Neratinib in Various Cancers  (10/15/2020)
• NCCN Oncology Research Program, with Taiho Oncology, to Explore New Research into Oral Medication Targeting Tumor Suppression Genes  (09/01/2020)
• NCCN Oncology Research Program Announces Projects Selected for Funding to Study Futibatinib in Tumors with Aberrant FGFR Expression, in Collaboration with Taiho Oncology  (07/23/2020)
• NCCN Explores Adoption of Biosimilars in Oncology in Collaboration with Pfizer  (07/15/2020)

NCCN Oncology Research Program (ORP) News Archive

Please select a year to view our archived press releases:

2020     2019     2018     2017     2016     2015     2014     2013     2012     2011     2010     2009     2008     2007     2006     2005     2003     2002    

For questions about NCCN or to request an interview, please contact Rachel Darwin, darwin@nccn.org.